Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$642K Sell
4,992
-512
-9% -$59.9K 0.5% 38
2026
Q1
$662K Sell
5,504
-786
-12% -$90.7K 0.58% 36
2025
Q4
$662K Buy
+6,290
New +$590K 0.58% 37

Other funds holding MRK

CrossGen Wealth's MRK Position: Q2 2026 in Review

CrossGen Wealth reduced its Merck (MRK) stake by 9.3% in Q2 2026, selling an estimated $59.9K and leaving 4,992 shares worth $642K. The position accounts for 0.5% of the portfolio, ranked #38.

CrossGen Wealth first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $662K in Q4 2025. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • CrossGen Wealth held 4,992 shares of Merck worth $642K as of Q2 2026.
  • CrossGen Wealth sold 512 Merck shares in Q2 2026, an estimated $59.9K.
  • Merck made up 0.5% of CrossGen Wealth's portfolio in Q2 2026, its #38 holding.
  • CrossGen Wealth first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • CrossGen Wealth's Merck position peaked at $662K in Q4 2025.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on CrossGen Wealth's 13F filing for Q2 2026, filed 24 Jul 2026.